Pfizer says RSV vaccine can ensure protection into second season
HQ Team March 1, 2024: Pfizer Inc., a US pharmaceutical and biotechnology corporation, announced its single dose of respiratory syncytial virus (RSV) vaccine.
Drugs
Health
Pharma
Drugs
Health
Pharma
Pfizer revamps organisation as $43 billion Seagen deal comes to close
HQ Team December 13, 2023: Pfizer is expected to close the $43 billion acquisition of Seagen by Thursday as the company announced restructuring.
Drugs
Health
Pharma
Pfizer Inc., stops twice-daily oral obesity drug trial at mid-stage
HQ Team December 2, 2023: Pfizer Inc., has discontinued its clinical trials of the twice-daily oral weight-loss drug, danuglipron, after more than 50%.
Drugs
Health
Pharma
CDC panel backs Pfizer’s respiratory virus vaccine to protect infants
HQ Team September 23, 2023: An advisory panel of the national public agency of the US, Centers for Disease Control and Prevention, has.
Drugs
Health
Pharma
Pfizer’s oral capsule Litfulo to treat hair loss gets EU approval
HQ Team September 19, 2023: The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss.
Drugs
Health
Pharma
Pfizer, BioNTech’s Covid-19 variant vaccine gets UK nod
HQ Team September 6, 2023: Britain’s Medicines and Healthcare products Regulatory Agency has cleared a vaccine made by Pfizer Inc., and its German.
Drugs
Medical
Pharma
FDA, EMA accept Pfizer’s BLP application for hemophilia therapy
HQ Team June 26, 2023: Pfizer Inc. announced that USFDA has accepted its biologics license application for treating bleeding disorders in adults through.
Drugs
Medical
Pharma
Sun Pharma buys three anti-inflammatory drug brands from Aksigen
Sun Pharmaceuticals announced it had acquired three brands from Aksigen to treat postoperative inflammation in patients undergoing minor surgery and dental procedures.